United Therapeutics | UTHR - Ebit

Aktienkurs
568.58
Täglich Wechseln
-7.21 -1.25%
Monatlich
-2.06%
Jährlich
86.21%
Q2 Prognose
557.15




Ebit Veränderung Datum
Amarin USD -2.26M 564K 2025-12
Ardelyx USD 5.1M 2.02M 2025-12
Baxter International USD 66M 280.2M 2026-03
Bayer EUR 3.53B 2.42B 2026-03
BioCryst Pharmaceuticals USD 260.38M 230.79M 2025-12
Biogen USD 514.3M 502.8M 2026-03
BioMarin Pharmaceutical USD 129.65M 68.74M 2026-03
Esperion Therapeutics USD 85.23M 95.19M 2025-12
Gilead Sciences USD 2.68B 284M 2026-03
GlaxoSmithKline GBP 2.29B 856M 2026-03
Halozyme Therapeutics USD -61.77M 26.64M 2026-03
Insmed USD -200.28M 49.43M 2026-03
Ionis Pharmaceuticals USD -118M 97M 2026-03
J&J USD 6.62B 1.51B 2026-03
Lexicon Pharmaceuticals USD -14.78M 2.59M 2025-12
Moderna USD -1.39B 531M 2026-03
Omeros USD -48.15M 7.25M 2023-09
Pfizer USD 4.99B 340M 2026-03
PTC Therapeutics USD 45.89M 127.51M 2026-03
Regeneron Pharmaceuticals USD 744.8M 153.8M 2026-03
Sarepta Therapeutics USD 358.43M 768.52M 2026-03
Teva Pharmaceutical Industries USD 758M 181M 2026-03
United Therapeutics USD 325.8M 340.4M 2026-03
Vertex Pharmaceuticals USD 1.14B 124.5M 2026-03